The combined effect of administration of intravenous and topical tranexamic acid on blood loss and transfusion rate in total knee arthroplasty: Combined tranexamic acid for TKA

OBJECTIVES: Tranexamic acid (TXA) is an antifibrinolytic agent used as a blood-sparing technique in total knee arthroplasty (TKA), and is routinely administered by intravenous (IV) or intra-articular (IA) injection. Recently, a novel method of TXA administration, the combined IV and IA application o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Z. F., Yin, H., Ma, W. P., Xing, D. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Knee
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013895/
https://www.ncbi.nlm.nih.gov/pubmed/27587787
http://dx.doi.org/10.1302/2046-3758.58.BJR-2016-0001.R2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013895/
https://www.ncbi.nlm.nih.gov/pubmed/27587787
http://dx.doi.org/10.1302/2046-3758.58.BJR-2016-0001.R2

Ejemplares similares